References
- https://insp.gov.ro/download/metodologia-de-supravegheregripa-infectii-respiratorii-acute-si-sari-2021-2022_actualizare-12-octombrie-2021-pdf/?wpdmdl=96151&refresh=658d40155f8641703755797
- Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza 2011. Geneva, WHO.
- Kikuchi C, Antonopoulos A, Wang S, Maemura T, Karamanska R, Lee C, et al. Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines. Nat Commun. 2023 Oct 4;14(1):6178. DOI: 10.1038/s41467-023-41908-0
- NISN IC50 Methodology (http://www.nisn.org/)
- Aifeng Li, Weihong W, Wenfang X, Jianzhi G. A microplate-based screening assay for neuraminidase inhibitors. Drug Discov Ther. 2009; 3(6):260-5.
- https://isirv.org/site/index.php/methodology/nai-assay-ic50
- Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012. Weekly epidemiological record. 2012;87(39):369-74.
- Okomo-Adhiambo M, Nguyen HT, Abd Elal A, Sleeman K, Fry AM, Gubareva LV. Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria. Influenza Other Respir Viruses. 2014 Mar;8(2):258-65. DOI: 10.1111/irv.12215
- Wong S, Pabbaraju K, Wong A, Fonseca K, Drews SJ. Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes. J Virol Methods. 2011 May;173(2):259-65. DOI: 10.1016/j.jviromet.2011.02.014
- van der Vries E, Anber J, van der Linden A, Wu Y, Maaskant J, Stadhouders R, van Beek R, Rimmelzwaan G, Osterhaus A, Boucher C, Schutten M. Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J Mol Diagn. 2013 May;15(3):347-54. DOI: 10.1016/j. jmoldx.2012.11.007
- Necula G, Mihai ME, Sbarcea CE, Dinu S, Lupulescu E, Ceausu E, et al. Overview of influenza virus antiviral resistance in Romania in the last four epidemic seasons - phenotyping, genotyping and molecular analysis study. Rev Romana Med Lab. 2011;19(3):227-40.
- European Centre for Disease Prevention and Control. Influenza virus characterization, summary Europe, June 2017. Stockholm: ECDC; https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-june-2017
- European Centre for Disease Prevention and Control. Influenza virus characterization, summary Europe, July 2018. Stockholm: ECDC; https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-july-2018
- European Centre for Disease Prevention and Control. Influenza virus characterization, summary Europe, July 2020. Stockholm: ECDC; https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-july-2020
- Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M, et al. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob Agents Chemother. 2015 May;59(5):2607-17.. DOI: 10.1128/AAC.04836-14
- Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, Kelso A. Community transmission of oseltamivir-resistant A(H1N1) pdm09 influenza. N Engl J Med. 2011 Dec 29;365(26):2541-2. DOI: 10.1056/NEJMc1111078
- Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis. 2012 Jul 15;206(2):148-57. DOI: 10.1093/infdis/jis337
- Bragstad K, Hungnes O, Litleskare I, Nyrerød HC, Dorenberg DH, Hauge SH. Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016. Influenza Other Respir Viruses. 2019 Jul;13(4):372-381. DOI: 10.1111/irv.12637
- Abed Y, Pizzorno A, Bouhy X, Boivin G. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains. Antiviral Res. 2015;114:57-61. DOI: 10.1016/j.antiviral.2014.12.006
- Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, et al. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog. 2014 Apr 3;10(4):e1004065. DOI: 10.1371/journal.ppat.1004065
- Groves HE, Piché-Renaud PP, Peci A, Farrar DS, Buckrell S, Bancej C, Sevenhuysen C, Campigotto A, Gubbay JB, Morris SK. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg Health Am. 2021 Sep;1:100015. DOI: 10.1016/j.lana.2021.100015